Biothera Pharmaceuticals to Present Clinical Data from Phase 2 Triple Negative Breast Cancer Study at ASCO 2019 Annual Meeting

    NEXT STORY
    Aptose to Present New Preclinical Data for CG-806 at the 24th Congress of The European Hematology Association
    PREV STORY
    Innovation Pharmaceuticals Announces Non-Binding Term Sheet Signed with Global Pharmaceutical Company to Develop and Commercialize Brilacidin for the Treatment of Ulcerative Proctitis/Ulcerative Proctosigmoiditis
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Severe Acute Respiratory Syndrome (SARS) Infection Drug Pipeline Study, H2 2018 – Analysis of Phases, Companies, Mechansim, Trials, & Current Status of Pipeline Drugs

    author_avatar
    NASDAQ Market News

    Midatech announces changes in Senior Management Team

    15 March 2018Midatech Pharma PLC("Midatech" or the "Company") Midatech announces changes in Senior Management ...

    author_avatar
    NASDAQ Market News

    Premier Diversified Holdings Inc. Closes $450K Private Placement and Announces Acquisitions

    VANCOUVER, British Columbia, Aug. 25, 2017 (GLOBE NEWSWIRE) -- Premier Diversified Holdings Inc. ("Premier" ...

    author_avatar
    NASDAQ Market News